succinylcholine has been researched along with gantacurium in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Caldwell, JE | 1 |
Belmont, MR; Bradley, E; Lien, CA; Patel, SS; Savarese, JJ; Stein, B; Tjan, J | 1 |
Belmont, MR; Heerdt, PM; Lien, CA | 1 |
Bruells, C; Pühringer, FK; Schälte, G; Zoremba, N | 1 |
1 review(s) available for succinylcholine and gantacurium
Article | Year |
---|---|
[Update on muscle relaxation : What comes after succinylcholine, rocuronium and sugammadex?]
Topics: Androstanols; Anesthesia; Animals; gamma-Cyclodextrins; Humans; Isoquinolines; Muscle Relaxants, Central; Neuromuscular Depolarizing Agents; Neuromuscular Nondepolarizing Agents; Rocuronium; Succinylcholine; Sugammadex | 2017 |
3 other study(ies) available for succinylcholine and gantacurium
Article | Year |
---|---|
The continuing search for a succinylcholine replacement.
Topics: Animals; Humans; Isoquinolines; Mivacurium; Neuromuscular Depolarizing Agents; Neuromuscular Nondepolarizing Agents; Succinylcholine | 2004 |
Clinical pharmacology of GW280430A in humans.
Topics: Adolescent; Adult; Blood Pressure; Dose-Response Relationship, Drug; Heart Rate; Histamine; Humans; Isoquinolines; Male; Middle Aged; Neuromuscular Nondepolarizing Agents; Succinylcholine | 2004 |
GW280430A: pharmacodynamics and potential adverse effects.
Topics: Anesthesia; Clinical Trials as Topic; Humans; Isoquinolines; Muscle Relaxants, Central; Succinylcholine | 2005 |